What if the neuropathy in front of you isn’t what it seems? Chronic inflammatory demyelinating polyneuropathy (CIDP) is the most common immune-mediated peripheral neuropathy, yet it remains widely underrecognized. Because its symptoms mimic other neuropathies, CIDP is too often misdiagnosed or caught late, delaying treatment and allowing preventable disability to accumulate. Meanwhile, the field is moving fast; new insight into autoantibody pathways [SMP1.1]and neonatal Fc-receptor (FcRn)-mediated pathways is reshaping how subtypes are classified and treated, yet less than 20% of community neurologists report using current European Academy of Neurology (EAN) / Peripheral Nerve Society (PNS) guidelines. This fast-paced recorded CaseWise symposium from CME Outfitters will bring real-world clinical decision-making to life. Through dynamic patient cases, learners will explore key clinical challenges to help sharpen diagnostic confidence, individualize treatment, and help patients achieve better long-term outcomes.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Address:
- 201 King of Prussia Rd.
Pricing
CME included with membership
| Integrative Psychiatry Certificate Program | $3,350 |
Collected from the provider’s public pages · source
Specialties served/covered
- Addiction Medicine
- Addiction Psychiatry
- Adolescent Medicine
- Allergy & Clinical Immunology
- Cardiovascular Disease
- Communication & Shared Decision-Making
- Critical Care Medicine
- Diagnostic Radiology
- Emergency Medicine
- Endocrinology, Diabetes & Metabolism
- Family Medicine
- Gastroenterology
- General & Adult Psychiatry
- General Internal Medicine
- General Operative Anesthesia
- General Otolaryngology
- General Pediatrics
- General Surgery
- Gynecologic Oncology
- Hematology
- Hospice & Palliative Medicine
- Medical Oncology
- Mood & Anxiety Disorders
- Neonatal-Perinatal Medicine
- Neurology
- Neuromuscular Medicine
- Neuroradiology
- Nuclear Medicine
- Obstetrics & Gynecology
- Ophthalmology
- Orthopaedic Surgery
- Pain Medicine
- Physical Medicine & Rehabilitation
- Practice Management & Ethics
- Primary Care Sports Medicine
- Pulmonary Disease
- Radiation Oncology
- Regional Anesthesia & Acute Pain
- Rheumatology
- Sleep Medicine
- Surgical Oncology
- Thoracic Surgery
- Urological Oncology
- Anesthesiology
- Cardio-Vascular
- Cross-Specialty
- Emergency & Critical Care
- ENT & Head Neck
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Orthopedics
- Pain & Palliative
- Pediatrics
- Primary care
- Psychiatry
- Radiology
- Rehabilitation
- Sports & Exercise Medicine
- Surgery
- Urology
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- On-demand / recorded video
- includes Case study / clinical scenario
- Credit · Up to 1 credit
- MOC · Up to 1 point
- Commercial Support
-
ReleasedOct 5, 2026
-
Last day to claim creditOct 6, 2027 12 months left
-
CME Outfitters, LLC A CaseWise Webcast – CIDP in Focus: Advancing Precision Across the Patient Journey from Early Recognition to Downstream Management
-
Efficient CME, CME Outfitters, LLC Time Out: Troubleshooting Complex and Evolving Situations in the Modern Diagnosis and Treatment of Chronic Demyelinating Polyneuropathy
-
CME Outfitters, LLC A CaseWise Webcast – Precision in Practice: Individualizing FcRn Inhibitor Use in Generalized Myasthenia Gravis
-
Medscape, LLC Rapid Fire on Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP): Answering Your Questions on Novel Therapies
-
Academy for Continued Healthcare Learning, The Implementing Multidisciplinary Clinical Protocols to Mitigate Diagnosis Delays, Optimize Treatment, and Ensure Safety in Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
-
Creative Educational Concepts, Inc. The MEKtrix: Decoding the Real-World Impact of Therapeutic Advances in Neurofibromatosis Type 1 Associated Plexiform Neurofibroma Management Across Pediatric and Adult Populations
